longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Pacific Biosc California

PACB

2.38030.05% ( +0.550 )
Trading: Sep 30, 13:13:52 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • 12 Health Care Stocks Moving In Wednesday's Intraday Session

    benzinga_article·7 minutes ago
    AEON+14.56%CMMB-24.60%
  • Niche Infrastructure Stocks Ride AI Data Center Power Surge

    Global Report·1 day ago, 09:15 AM
    LBRT-2.09%SOFX-0.84%
  • Kodiak Sciences, AMC Entertainment, Agenus And Other Big Stocks Moving Higher On Monday

    benzinga_article·1 day ago, 06:25 PM
    - U.S. stocks experienced a decline on Monday, while several individual equities recorded significant gains. - Kodiak Sciences surged 174 % to $88.79 following positive Phase 3 trial data for its wAMD treatments. - Other notable movers included Chaince Digital Holdings, AMC Entertainment, and Agenus, driven by corporate actions and positive analyst coverage.
    00847G8040.00%AGEN-1.92%
  • The Quiet Reckoning of US Biotech: Survival Beyond the Science

    Global Report·Sep 24 at 10:46 AM
    PACB+30.60%CDNA-0.77%
  • Biotech Earnings Diverge as Diagnostics Surge and Equipment Makers Retrench

    Global Report·Sep 24 at 09:17 AM
    CDNA-0.77%PACB+30.60%
  • Pacific Biosciences Targets Clinical Growth, $40M Savings With HiFi Sequencing Push

    Market Beat·Sep 20 at 06:02 AM
    PACB+30.60%
  • Tectonic Therapeutic CEO to join Morgan Stanley Global Healthcare Conference fireside chat

    PUBT·Sep 3 at 12:02 PM
    MS-1.49%
  • STOCKS | Nasdaq Biotechnology Index Falls More Than 2.7% as Xencor Drops 9.76%

    CoinLive·Aug 28 at 09:42 PM
    IVVD+0.58%ABCL+0.07%
  • A Year of Transitions: Navigating the Complex Realities of Biotech, Green Energy, and Global Manufacturing

    Global Report·Aug 25 at 09:20 AM
    SAFX-0.76%DHR-1.00%
  • M&A, Buybacks and C-Suite Shifts: KeyCorp and FactSet Top Estimates as PacBio Slashes Outlook

    Global Report·Aug 18 at 09:43 AM
    KEY-0.07%ZION+0.13%
  • PacBio Cuts Outlook as SPRQ-Nx Transition Slows, Targets 2028 Cash-Flow Positivity

    Market Beat·Aug 16 at 07:01 AM
    PACB+30.60%
  • Niche US Equities See Volatile Q3 With UWM's Historic USD 2 Billion Raise and Sector-Wide AI Pivots

    Global Report·Aug 7 at 09:18 AM
    UWMC-1.21%ALAR-4.91%
  • PacBio releases transcript of 2Q26 earnings call

    PUBT·Aug 6 at 11:15 PM
    PACB+30.60%
  • Canaccord Genuity Sticks to Their Buy Rating for Pacific Biosciences (PACB)

    Tip Ranks·Aug 6 at 11:11 AM
    PACB+30.60%PIPR+2.21%